Clinical trial
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
NCT06520410 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 5, 2024
- Completion date
- February 28, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coats disease, coats retinopathy, familial exudative vitreoretinopathies, persistent fetal vasculature, retinal disease, retinal vascular disorder, retinopathy of prematurity both eyes, vitreous anomalies, vitreous disorder